Michael Milone and Saba Ghassemi (Penn)
A team at Penn says it has slashed CAR-T cell therapy manufacturing timeframe to just 24 hours
The future of CAR-T cell therapy research has come a long way over the years, but scientists have still been plagued by one problem: how …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
